QA: 2Seventy bio Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860782_2025_2Seventy_bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 0.9176458670988655, 'aggregate_val': 37862000, 'exp_sum': 19744000, 'exp_to_value': {'remainder_Revenues': 19744000}}

Graph

Absolute values for 0001860782, 2Seventy bio Inc

  xvar xval
0 AssetsCurrent 187,256,000
1 IntangibleAssetsNetIncludingGoodwill 5,885,000
2 PropertyPlantAndEquipmentNet 33,759,000
3 remainder_Assets 252,610,000
4 LiabilitiesCurrent 40,092,000
5 LiabilitiesNoncurrent 228,612,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 643,014
8 SellingGeneralAndAdministrativeExpense 46,272,069
9 ResearchAndDevelopmentExpense 77,922,834
10 remainder_Expenses 27,562,359
11 remainder_Revenues -4,200,089
12 remainder_NetIncome 17,242,074
13 remainder_ComprehensiveNetIncome 1,382,244
  yvar yval
0 Assets 479,510,000
1 Liabilities 268,704,000
2 Expenses 152,400,276
3 Revenues -4,200,089
4 StockholdersEquity 210,806,000
5 NetIncome -139,358,291
6 ComprehensiveNetIncome -138,667,169
7 BaseVar 461,719,342
8 EconomicCapitalRatiobeforeLimitedLiability 0.858
9 EconomicCapitalRatio 2.19

Edgar->Model Mapping

Feature Distribution

Change over Time